Post by JHam on May 20, 2015 12:22:54 GMT
More from the PR blitz. They are presenting new data from ongoing pre-clinical and clinical trials. The title of the abstract is very encouraging:
OncoSec Medical to Present Data at the New York Academy of Sciences' Cancer Immunotherapy Symposium
ir.oncosec.com/press-releases/detail/1820
"Intratumoral Expression of Plasmid IL-12 Can Increase CD8 TILs and Drive Systemic Anti-Tumor Responses: Rationale for Combination with Anti-PD-1 Blockade"
OncoSec Medical to Present Data at the New York Academy of Sciences' Cancer Immunotherapy Symposium
ir.oncosec.com/press-releases/detail/1820
"Intratumoral Expression of Plasmid IL-12 Can Increase CD8 TILs and Drive Systemic Anti-Tumor Responses: Rationale for Combination with Anti-PD-1 Blockade"